RxDoctor Payments Data

Monica Juarez-Gonzalez, DO

Family Medicine · Dallas, TXNPI 1578853776

Payments from drug & device makers

$2,612in general payments, 2019–2025

Across 154 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$470
  • AstraZeneca$389
  • Pfizer$324
  • Merck$246
  • Amarin Pharma, Inc.$240
  • Boehringer Ingelheim$112
  • plus $831 from 16 others

What the payments were for

  • Food & beverage$2,612100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,612 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$14,185
Medicare patients
74
Services billed
205

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin73$119,310
OzempicSemaglutide46$69,630
MounjaroTirzepatide25$48,894
TrulicityDulaglutide33$41,120
JanuviaSitagliptin Phosphate16$29,516
LinzessLinaclotide20$29,226
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,417
SymbicortBudesonide/Formoterol Fumarate13$3,204
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$3,071
Atorvastatin Calcium367$2,650
Albuterol Sulfate HfaAlbuterol Sulfate64$1,815
Humulin 70-30Insulin Nph Hum/Reg Insulin Hm11$1,527
Fluticasone Propionate74$1,513
Gabapentin78$1,297
Lisinopril218$1,174

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$112$119,31073 claims
Lilly USA, LLCMounjaro, Trulicity, Humulin 70-30$56$91,54169 claims
Novo NordiskOzempic$470$69,63046 claims
MerckJanuvia$246$29,51616 claims
AbbVieLinzess$110$29,22620 claims
AstraZenecaBreztri Aerosphere, Symbicort$389$11,62226 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →